Nurix Therapeutics officer plans $558K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Christine Ring, an officer of Nurix Therapeutics, Inc. (NRIX), reported an intended sale of 28,935 common shares, with an approximate sale date of June 25, 2026 and an aggregate market value of $558,445.50. She acquired 28,935 shares from the issuer on June 25, 2026, through a stock-option exercise paid for in cash. The form lists 103,405,813 common shares outstanding.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Aggregate Market Value financial
Exercise of Stock Options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.